Commercialization challenges for drug eluting contact lenses

Area of Science:

• Ophthalmic drug delivery
• Biomaterials science
• Contact lens technology

Background:

• Eye drops have limitations in bioavailability and patient compliance for ophthalmic drug delivery.
• Contact lenses offer higher bioavailability but suffer from rapid drug release, limiting their therapeutic potential.

Purpose of the Study:

• To review methods for prolonging drug release from contact lenses.
• To evaluate the commercial viability and challenges of drug-eluting contact lenses.

Main Methods:

• Review of current literature on contact lens drug delivery modifications.
• Analysis of technologies including molecular imprinting, nanoparticles, vitamin-E barriers, and layered lenses.
• Evaluation of commercialization barriers and ongoing research.

Main Results:

• Several technologies show promise for sustained drug release from contact lenses.
• Challenges remain in safety, acceptance, production, storage, and maintaining lens properties.

Conclusions:

• Drug-eluting contact lenses have significant potential to improve ophthalmic treatment.
• Despite hurdles, ongoing research suggests future commercialization is likely.